Neuropsychiatric Symptom Burden across Neurodegenerative Disorders and its Association with Function.


Journal

Canadian journal of psychiatry. Revue canadienne de psychiatrie
ISSN: 1497-0015
Titre abrégé: Can J Psychiatry
Pays: United States
ID NLM: 7904187

Informations de publication

Date de publication:
05 2023
Historique:
medline: 18 5 2023
pubmed: 14 1 2023
entrez: 13 1 2023
Statut: ppublish

Résumé

Neuropsychiatric symptoms (NPS) are prevalent in neurodegenerative disorders, however, their frequency and impact on function across different disorders is not well understood. We compared the frequency and severity of NPS across Alzheimer's disease (AD) (either with mild cognitive impairment or dementia), Cerebrovascular disease (CVD), Parkinson's disease (PD), frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS), and explored the association between NPS burden and function. We obtained data from Ontario Neurodegenerative Disease Research Initiative (ONDRI) that included following cohorts: AD ( Frequency of NPS varied across cohorts (χ NPS frequency and severity are markedly greater in FTD as compared to other neurodegenerative diseases. Further, NPS burden appears to be associated differently with function across neurodegenerative disorders, highlighting the need for individualized clinical interventions.

Identifiants

pubmed: 36637224
doi: 10.1177/07067437221147443
pmc: PMC10192827
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

347-358

Références

J Alzheimers Dis. 2022;86(2):827-840
pubmed: 35147535
J Clin Neurosci. 2012 Apr;19(4):552-6
pubmed: 22249015
J Psychopharmacol. 2018 May;32(5):509-523
pubmed: 29338602
BMC Geriatr. 2016 Aug 22;16:154
pubmed: 27549203
J Neurol Sci. 1999 Oct 31;169(1-2):13-21
pubmed: 10540002
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
Int Psychogeriatr. 2022 Oct;34(10):919-928
pubmed: 35546289
Mov Disord. 2007 Jan;22(1):41-7
pubmed: 17115387
Hum Psychopharmacol. 2003 Apr;18(3):215-20
pubmed: 12672174
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Cogn Behav Neurol. 2004 Dec;17(4):185-90
pubmed: 15622012
Mov Disord. 2009 Nov 15;24(15):2175-86
pubmed: 19768724
Can J Neurol Sci. 2017 Mar;44(2):196-202
pubmed: 28003035
Ther Adv Neurol Disord. 2017 Aug;10(8):297-309
pubmed: 28781611
J Am Med Dir Assoc. 2015 May 1;16(5):380-7
pubmed: 25687925
Front Neurosci. 2019 Mar 11;13:175
pubmed: 30914912
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Int J Geriatr Psychiatry. 2008 Feb;23(2):170-7
pubmed: 17607801
J Neurol Sci. 2005 Sep 15;236(1-2):43-8
pubmed: 15964021
Curr Alzheimer Res. 2010 Sep;7(6):517-26
pubmed: 20455862
Int Psychogeriatr. 2012 Dec;24(12):1980-7
pubmed: 22835209
Alzheimers Dement (N Y). 2017 Aug 05;3(3):440-449
pubmed: 29067350
Dement Neuropsychol. 2015 Jul-Sep;9(3):230-236
pubmed: 29213966
BMC Geriatr. 2018 Jul 9;18(1):159
pubmed: 29986669
Front Aging Neurosci. 2019 Jul 24;11:176
pubmed: 31396074
BMC Geriatr. 2021 Oct 20;21(1):581
pubmed: 34670502
Curr Alzheimer Res. 2012 Jul;9(6):759-71
pubmed: 22715983
J Geriatr Psychiatry Neurol. 2008 Jun;21(2):133-41
pubmed: 18474722
BMJ. 2022 Jan 25;376:e069187
pubmed: 35078774
J Parkinsons Dis. 2015;5(3):659-67
pubmed: 26406147
Am J Psychiatry. 2015 May;172(5):460-5
pubmed: 25585033

Auteurs

Daniel Kapustin (D)

Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Adult Neurodevelopmental and Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.

Shadi Zarei (S)

Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Adult Neurodevelopmental and Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.

Wei Wang (W)

Adult Neurodevelopmental and Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.

Malcolm A Binns (MA)

Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Rotman Research Institute at Baycrest Health Sciences, Toronto, ON, Canada.

Paula M McLaughlin (PM)

Nova Scotia Health, Halifax, Nova Scotia, Canada.

Agessandro Abrahao (A)

Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.
Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Department of Medicine (Neurology), University of Toronto, Toronto, ON, Canada.

Sandra E Black (SE)

Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.
Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Department of Medicine (Neurology), University of Toronto, Toronto, ON, Canada.
LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.

Michael Borrie (M)

University of Western Ontario, London, ON, Canada.

David Breen (D)

Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.

Leanna Casaubon (L)

Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.

Dar Dowlatshahi (D)

Department of Medicine (Neurology), University of Ottawa Brain and Mind Institute and Ottawa Hospital Research Institute, Ottawa, ON, Canada.

Elizabeth Finger (E)

University of Western Ontario, London, ON, Canada.

Corinne E Fischer (CE)

Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Keenan Research Centre for Biomedical Science, St. Michaels Hospital, Toronto, Ontario, Canada.

Andrew Frank (A)

University of Ottawa, Ottawa, ON, Canada.
Bruyere Research Institute, Ottawa, ON, Canada.

Morris Freedman (M)

Rotman Research Institute at Baycrest Health Sciences, Toronto, ON, Canada.
Department of Medicine (Neurology), University of Toronto, Toronto, ON, Canada.

David Grimes (D)

Department of Medicine (Neurology), University of Ottawa Brain and Mind Institute and Ottawa Hospital Research Institute, Ottawa, ON, Canada.

Ayman Hassan (A)

Thunder Bay Regional Research Institute, Northern Ontario School of Medicine, ON, Canada.

Mandar Jog (M)

University of Western Ontario, London, ON, Canada.

Donna Kwan (D)

Queen's University, Kingston, ON, Canada.

Anthony Lang (A)

Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.
Department of Medicine (Neurology), University of Toronto, Toronto, ON, Canada.
Edmond J. Safra Program in Parkinson's Disesase and the Morton and Gloria Shulman Movement Disorders Centre, University Health Network, Toronto, ON, Canada.

Brian Levine (B)

Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.

Jennifer Mandzia (J)

University of Western Ontario, London, ON, Canada.

Connie Marras (C)

Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.
Department of Medicine (Neurology), University of Toronto, Toronto, ON, Canada.
Edmond J. Safra Program in Parkinson's Disesase and the Morton and Gloria Shulman Movement Disorders Centre, University Health Network, Toronto, ON, Canada.

Mario Masellis (M)

Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.
Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Department of Medicine (Neurology), University of Toronto, Toronto, ON, Canada.

Joseph B Orange (JB)

Canadian Centre for Activity and Aging, Western University, ON, Canada.

Stephen Pasternak (S)

University of Western Ontario, London, ON, Canada.
Robarts Research Institute and the Department of Medical Biophysics, The University of Western Ontario, London, ON, Canada.

Alicia Peltsch (A)

Queen's University, Kingston, ON, Canada.

Bruce G Pollock (BG)

Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Adult Neurodevelopmental and Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.

Tarek K Rajji (TK)

Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Adult Neurodevelopmental and Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Dementia Research Alliance, University of Toronto, Toronto, Ontario, Canada.

Angela Roberts (A)

School of Communication, Northwestern University, Evanston, Illinois, USA.
School of Communication Sciences and Disorders, Western University, London, Ontario, Canada.

Demetrios Sahlas (D)

McMaster University, Hamilton, ON, Canada.

Gustavo Saposnik (G)

Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.

Dallas Seitz (D)

Department of Psychiatry and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Christen Shoesmith (C)

Division of Neurology, Department of Clinical Neurological Sciences, London Health Sciences Centre, London, ON, Canada.

Alisia Southwell (A)

Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Thomas D L Steeves (TDL)

Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.
Department of Medicine (Neurology), University of Toronto, Toronto, ON, Canada.
University of Ottawa, Ottawa, ON, Canada.

Kelly Sunderland (K)

Rotman Research Institute at Baycrest Health Sciences, Toronto, ON, Canada.

Richard H Swartz (RH)

Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.
Department of Medicine (Neurology), University of Toronto, Toronto, ON, Canada.
Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Brian Tan (B)

Rotman Research Institute at Baycrest Health Sciences, Toronto, ON, Canada.

David F Tang-Wai (DF)

Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.
Department of Medicine (Neurology), University of Toronto, Toronto, ON, Canada.
Krembil Brain Institute, Toronto Western Hospital, Toronto, ON, Canada.
Toronto Western Hospital, University Health Network Memory Clinic, Toronto, ON, Canada.

Maria Carmela Tartaglia (MC)

Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.
Department of Medicine (Neurology), University of Toronto, Toronto, ON, Canada.
Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.

Angela Troyer (A)

Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.
Neuropsychology and Cognitive Health Program, Baycrest Health Sciences, Toronto, ON, Canada.

John Turnbull (J)

McMaster University, Hamilton, ON, Canada.

Lorne Zinman (L)

Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.
Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Department of Medicine (Neurology), University of Toronto, Toronto, ON, Canada.

Sanjeev Kumar (S)

Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Adult Neurodevelopmental and Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH